Palivizumab, CAS [[188039-54-5]]

Produktübersicht

• Artikelname: Palivizumab, CAS [[188039-54-5]]
• Artikelnummer: TGM-T76907
• Hersteller Artikelnummer: T76907
• Alternativnummer: TGM-T76907-1MG, TGM-T76907-5MG, TGM-T76907-10MG, TGM-T76907-25MG, TGM-T76907-50MG, TGM-T76907-100MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: MEDI 493, Synagis

Produktbeschreibung

Palivizumab (MEDI 493) is a humanized RSV-specific monoclonal antibody that selectively inhibits epitopes at the F protein A antigenic site of RSV subtypes A and B for the prevention of respiratory syncytial virus infection (RSV).

Produkteigenschaften

• CAS Nummer: [188039-54-5]
• Target-Kategorie: RSV